TY - JOUR
T1 - Human synovial sarcoma proto-oncogene Syt is essential for early embryonic development through the regulation of cell migration
AU - Kimura, Taichi
AU - Sakai, Mieko
AU - Tabu, Kouichi
AU - Wang, Lei
AU - Tsunematsu, Ryosuke
AU - Tsuda, Masumi
AU - Sawa, Hirofumi
AU - Nagashima, Kazuo
AU - Nishihara, Hiroshi
AU - Hatakeyama, Shigetsugu
AU - Nakayama, Keiko
AU - Ladanyi, Marc
AU - Tanaka, Shinya
AU - Nakayama, Keiichi I.
N1 - Funding Information:
We thank Dr Ken Sasai (Hokkaido University) and Hiroaki Hiraga (Sapporo Cancer Center) for useful suggestions. This study was supported in part by grants-in-aid from the Ministry of Education, Science, Culture, and Sports, and from the Ministry of Health, Labor, and Welfare; and also by the YASUDA Medical Research Foundation, by the Suhara Foundation, by the Mochida Memorial Foundation for Medical and Pharmaceutical Research and by the UEHARA Medical Research Foundation.
PY - 2009/6
Y1 - 2009/6
N2 - SYT-SSX protein, resulted from chromosomal translocation, causes synovial sarcoma, which is a malignant tumor accounting for 10% of soft tissue sarcoma. However, biological functions of SYT (synovial sarcoma translocation), also known as SS18, are largely unclear, whereas it has been proven that Syt-null mice die at early stages of embryonic development. Here, we generated Syt-deficient mice and confirmed the reported phenotypes, including growth retardation, open neural tube and haplo-insufficient lethality, and therefore, there is no doubt that Syt is essential for embryonic development. However, placental defects, described in the earlier report, were rarely seen in our mice and we frequently observed cardiac defect in Syt-deficient mice. As the mechanisms responsible for embryonic lethality seem to be complicate, we performed additional experiments. By using primary cultured embryonic fibroblasts, we showed that Syt / MEFs deregulate actin organization and suppressed cell migration. These observations suggest that Syt may contribute to the signaling pathway important for various cellular functions in vivo and in vitro, and we propose that Syt-deficient MEFs would be a powerful means to understand the biological roles of SYT in vitro.
AB - SYT-SSX protein, resulted from chromosomal translocation, causes synovial sarcoma, which is a malignant tumor accounting for 10% of soft tissue sarcoma. However, biological functions of SYT (synovial sarcoma translocation), also known as SS18, are largely unclear, whereas it has been proven that Syt-null mice die at early stages of embryonic development. Here, we generated Syt-deficient mice and confirmed the reported phenotypes, including growth retardation, open neural tube and haplo-insufficient lethality, and therefore, there is no doubt that Syt is essential for embryonic development. However, placental defects, described in the earlier report, were rarely seen in our mice and we frequently observed cardiac defect in Syt-deficient mice. As the mechanisms responsible for embryonic lethality seem to be complicate, we performed additional experiments. By using primary cultured embryonic fibroblasts, we showed that Syt / MEFs deregulate actin organization and suppressed cell migration. These observations suggest that Syt may contribute to the signaling pathway important for various cellular functions in vivo and in vitro, and we propose that Syt-deficient MEFs would be a powerful means to understand the biological roles of SYT in vitro.
KW - Cardiogenesis
KW - Embryonic lethality
KW - Motility
KW - P300
KW - Synovial sarcoma
KW - Syt
UR - http://www.scopus.com/inward/record.url?scp=66549088711&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=66549088711&partnerID=8YFLogxK
U2 - 10.1038/labinvest.2009.25
DO - 10.1038/labinvest.2009.25
M3 - Article
C2 - 19333234
AN - SCOPUS:66549088711
SN - 0023-6837
VL - 89
SP - 645
EP - 656
JO - Laboratory Investigation
JF - Laboratory Investigation
IS - 6
ER -